Tuesday, October 28, 2014

How Wearables Can Meet Aggressive Projections

Pin It Now!
Wearable technology is expected to grow to be a $30 billion market by 2018 but while many people are beginning to come around on the benefits, there are still plenty of reasons to be skeptical.  According to a recent report from PWC, 86% of consumers believe wearables make us vulnerable to security breaches, 82% believe it invades their privacy and 72% feel it hurts our ability to relate to other humans.

That said, there are still many out there that feel strongly about the benefits wearables have to offer.  Of that same group, more than three-quarters believe wearables are important for them to get more out of their time with another 74% of the belief that the technology can help to relieve stress.  Many also believe they can offer a number of other health benefits (although these non-medical opinions are probably best taken with a grain of salt).  This begs the question of what can be done to encourage users to adopt this technology and in turn, reap these benefits. 

Not surprisingly, respondents indicated that monetary assistance would go a long way in their adoption.  For every demographic across every type of wearable device, price was the number one barrier to adoption.  While almost three-quarters (72%) of respondents would be willing to utilize a smart watch if an institution paid for it, that number dropped to 42% if the consumer was theoretically responsible for $100 of that cost.  Interestingly enough, consumers still showed a strong aversion to smart glasses (generally the most expensive in this category) even with the monetary aspect absent from the equation.


Brand also proved to have a strong correlation to consumer’s willingness to adopt these technologies.  No real surprise here: Users are more willing to experiment with technology from traditional tech giants—Apple, Amazon, Google—then any other brand.  The conclusion we can draw from this? As the report states, “In a market that is saturated with technology for innovation’s sake, we don’t need more innovation—we need more meaningful applications.”  We need meaningful disruption.  A category that a theoretical McDonald’s smart watch may not necessarily qualify for.    


All other things being equal, users indicated they’d be more likely to adopt this technology if that adoption itself was incentivized.  More than half of millennials said they’d be strongly motivated to utilize a device if it had “apps/features that reward those who frequently use it with monetary rewards.”  Similarly, 70% of overall respondents said they’d be willing to wear an employer-provided wearable if it meant breaks on their insurance premiums.

It remains to be seen whether the enormous projections about wearables will come to fruition.  Until then, all we can do is speculate on the number of Fitbit-toting, smart watch-wearing “Glassholes”. 

We’ll have more on the latest in wearables and pharma marketing at ePharma. Join us February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz

Sign up for our email updates
Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  



Friday, October 24, 2014

ePharma Buzz- 10/24

Pin It Now!
#ePharma news waits for no man.  As digitally connected as we all are, it’s easy to miss a thing or two over the course of a busy week.  Are you guilty of putting down your phone, iPad or laptop for an hour or two these last few days?  No sweat.  We took the liberty of pulling together some worthwhile pieces of news from this past week.   

Uber's Well-Suited For House Calls — Uberhealth Should Live On, Venture Beat- We've seen several tech giants begin to delve into healthcare lately.  Could Uber be the latest on that list?  The company executed a one-day pilot with Harvard medical school to deliver flu vaccinations in New York City, D.C. and Boston yesterday.  All shots are administered by a registered RN.  The vaccinations are at no cost to the patient but Uber does ask that you have a “suitable indoor environment” ready before the nurse arrives.  The pilot program was available for a five hour window (although it's unclear how a strike by NYC Uber drivers may have disrupted some of those plans).    

Alyssa Greenberg for Uber

Amy Price: Patients Doing Research For Themselves, The BMJ- Should patients be “allowed” to do their own research?  Some feel that they can do more harm than good with this sort of “self-experimentation”.  Amy Price shows that patients do in fact have a track record of successfully researching and self-managing their own conditions.  This begs the question as to whether those without medical training can contribute to health innovation.  The article cites some examples that answer that question.  

5 Reasons Why Digital Pharma Needs Physician Key Opinion Leaders¸ mHealth News- David Lee Scher (@dlschermd) writes that physician key opinion leaders (KOLs) will pave the way for provider acceptance of shared decision making.  He projects the arrival of a new group of digital KOLs will compliment the traditional group.  One of his arguments for the establishment of this new group is that “physicians are at the crossroads of all things medical and digital.” He sees patient portals as the future digital hub of healthcare and the “gateway to connected health.”  David’s other four arguments can be found in the article.

Back to the Future of Medicine: 3 Reasons Why Healthcare Needs Hackathons, LinkedIn- Healthcare and tech are beginning to overlap in more and more instances so naturally, we’re seeing the growth of healthcare hackathons.  Aman Bhandari (@GHideas) and Sachin Jain (@sacjai) have analyzed over 100 health related hackathons since they say the first one was launched in 2010.  According to that data, there have been 51 to date this year in comparison to 36 last year and 23 the year before.  “The hackathon model, while not a cure-all provides an unparalleled innovation opportunity,” writes Bhandari.


Drugmakers May Need Indemnity For Fast-Tracked Ebola Vaccines¸ Reuters- Drug makers are reportedly looking for some type of protection for governments against potential claims stemming from any emergency use of new Ebola vaccines in Africa.  GSK Chief Executive Andrew Witty is quoted as saying that a system of indemnity makes sense given the unique circumstances brought on by this situation.  Witty said the indemnity would not be necessary for early clinical trial programs but would be important down the road.  A high level meeting to discuss the topic was held in Geneva late yesterday. 

We’ll have more on the latest in the field of pharma marketing at ePharma. Join us February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz

Sign up for our email updates
Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  



Thursday, October 23, 2014

Pharma Salaries Dip Across the Board

Pin It Now!
The results of this year’s MM&M salary survey may be a case of the glass half full versus glass half empty conundrum.  Salaries across the board were down 5.5% but at the same time, it was the second highest average in the 28 year history of the survey.  This may come as a surprise to some given the state of competition for talent in the industry. “The growth that I’ve seen and the turnaround in the industry in the past 18 months has really caused an increase in competition for top talent, which comes with paying some money,” according to Frank Powers, Dudnyk President.  

The average salary figure, of course, only begins to tell the story as the dips in salary varied across market sector, company size and type of employer.  The biggest discrepancy, however, lies in the average salary by gender. 

Those employed by manufacturers in pharma fared “less badly” than most of their peers.  These salaries reflected only a 2.9% decline year-over-year compared to those working in agency (11.2%), professional media (6.5%) and consumer media (17.7%) settings.  Only the group classified as service suppliers and vendors showed an increase (4.7%) however this represented only 9% of the total respondents.  Some of this may be attributable to pharma increasingly looking outside the organization/industry for help with certain digital capabilities and tech initiatives—expertise that’s proved difficult to come by within the field. 

Pharma salary average employer pharmaceutical

In terms of specific market sectors, prescription pharma fared the best in a situation where there was drop-off across the board.  That segment showed only a 3.3% decline while the rest of the industry had drop-offs between 12% and 23%.  

Pharma average salary market sector pharmaceutical

The biggest disparity in average salary lies in gender with female respondents making, on average, only 75% of what their male counterparts are paid.  According to this survey, many of the upper level jobs in pharma are currently dominated by men.  The positions of President (80%), CEO (87%), Executive VP (84%), Research Director (75%) and Sales Director (84%) all skewed heavily male.  At the same time, some of the more junior positions such as Account Supervisor (65%) and Account Manager (61%) had the majority represented by women.

Pharma is actually not far off from the rest of the country in this regard.  As a generally accepted figure, women on average make about 77% of what men make in the US. 

The full results of the MM&M survey can be found here.  

We’ll have more on the latest in the field of pharma marketing at ePharma. Join us February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz

Sign up for our email updates
Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  



Monday, October 20, 2014

Microsoft Smart Watch to Be Unveiled in Coming Weeks

Pin It Now!
The smart watch market is projected to be worth about $7.1 billion in 2015 and it would appear that Microsoft has every intention of being a player in this potentially lucrative space. Forbes is reporting that the company has plans to unveil a wearable device within in the next few weeks capable of tracking a user’s heart rate.  The device will reportedly work across a number of different platforms in addition to Windows phones including iPhone and Android.  

The device appears to be similar to the Moto 360, which also has the capability of monitoring a user’s heart rate, but can supposedly hold a battery charge for over two days with regular use.  This would set it apart from similar devices which require a charge after a single day’s use. 

Microsoft intends to have its new hardware on the shelves within the next few weeks—just in time for the holiday rush.  It was reported earlier this year that the company had plans for this type of device but the exact timeline of its release was unknown. 

This is only the latest move among tech giants in the suddenly competitive space of health data aggregation.  Apple and Google have both received plenty of attention for their plans for health aggregators and wearable devices this year.  In addition, the Apple Watch is expected to become available early 2015.  

As far as wearable devices go, the intrigue certainly appears to be there but adoption remains an issue.  A survey from earlier this year showed that one-third of consumers who purchased a wearable device gave up on using it within six months.  Nonetheless, this showed an increase from the year prior so while that rate remains low, it appears to be trending upward.

Within months, Apple, Mircrosoft and Google will all have health data aggregators and accompanying wearable devices available and the competition for this lucrative market will seemingly be in full swing.

Photograph: USPTO

We’ll have more on the latest in the field of wearable technology at ePharma. Join us February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz
Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  



Friday, October 17, 2014

ePharma Buzz- 10/17

Pin It Now!
It's almost Friday afternoon which means it's time to start checking out mentally. Maybe? Either way, here’s a list of five articles worth a glance from this past week. 

10 Inevitable Changes in Pharma 2015, Richie Etwaru on LinkedIn- Only ten inevitable changes for the pharma industry next year may be a conservative projection but Richie Etwaru (@RichieEtwaru) has outlined some of the most important.  He reviews some of the changing vernacular in the industry such as the transition from “care” to “cure”.  One that we thought was spot on: The change from “customer” to “consumer”.  With the physician being the customer and the patient being the consumer, the pressure is now on pharma to increasingly focus on the former rather than the latter.

Developing a Global Digital Strategy, Gail Horwood- Johnson & Johnson’s VP of Digital Strategy believes “digital brings opportunities to streamline and leverage certain capabilities that are really common across [all] businesses.”  Included in those opportunities is real-time marketing, and included in that category is social media.  J&J took advantage of this during this past World Cup by building a campaign around Listerine.  The company built two newsrooms and responded to developments in matches in real-time with appropriate brand messages.  The biggest takeaway from their success was that real-time marketing is as much about pre-planning as it is anything else. 

This Startup's Robots Could Stop Ebola in Its Tracks, Inc.- Could a robot potentially disinfect an entire room?  It might not be as crazy as it sounds.  Xenex’s new “virus-zapping” robot can effectively stop the spread of disease by using ultraviolet light to disinfect contaminated spaces.  This technology has gotten even more attention following the first Ebola death in the US last week.  "It looks like a car wash for beds. But it's a light wash," explained Xenex CEO Morris Miller.  



mHealth: The Most Underutilized Force in Patient Engagement?, HIT Consultant- [Insert staggering mobile phone usage stat here].  The question everyone is searching for the answer to: How can we better leverage that usage in healthcare?  James Dias lists five steps for healthcare organizations to get started.  Start with getting the patient’s number which is often more difficult than it sounds.  Make it a required field on registration forms.

Cigna Launches Gamified Digital Health Coaching, FierceHealthPayer- Cigna is aiming to improve consumer adoption of their diet and exercise apps through their new gamification effort, Cigna Health Matter.  After enrolling in a program, members can begin interacting with a digital health assessment that incorporates metrics such as BMI, cholesterol and blood pressure.  Users are scored based on these variables and in turn can earn rewards for completing activities and reaching certain milestones.  “During the past several years, we've learned the importance of connecting health improvement to tangible, immediate, recognition and incentives," said Eric Herbek, VP of Product Development.  

Save the date! ePharma will take place February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz


Sign up for our email updates
Follow us on Twitter
Join us on LinkedIn
Check us out Facebook 



Tuesday, October 14, 2014

How Healthcare Providers and Insurance Companies Can expand the mHealth Market

Pin It Now!
So-called “mHealth” is one of the most interesting sectors of modern healthcare, and holds the possibility of reshaping patient-outcome monitoring and preventative practices. At the heart of mHealth is the adoption of consumer health and fitness-tracking devices, and their integration into the medical industry. If healthcare providers can convince a majority of their patients to use and share data from tracking devices, they could analyze trends in their patient population and provide individuals with tailored healthcare advice.

To help providers find the best strategies for engaging their patients and encouraging health tracking, TechnologyAdvice conducted a nationwide survey of US adults, looking at these issues. 419 adults, who reported that they did not currently track their diet, weight, or exercise using a fitness tracker or smartphone app, were surveyed about their reasons for not tracking and what incentives might encourage them to do so.

Based on the results, there are large opportunities for both healthcare providers and health insurance companies to promote widespread fitness tracking.

One potential option would be for physicians to provide wearable devices to their patients, free of charge. When survey respondents were asked whether they would use a physician-provided fitness tracker, 48.2 percent said they would. 

Willingness to Use a Free Fitness Tracker Provided by a Physician


That means physicians could get nearly half of their non-tracking patients to start using such devices, simply by providing them. Even if such a program is financially impractical, it’s likely that providing the devices at reduced costs (subsidizing them) would be effective as well.

Health insurance companies could also play a key role in encouraging health and fitness tracking. While just under half of respondents said they would use a free fitness tracker, 57.1 percent said they would be more likely (or much more likely) to adopt digital fitness tracking if they could receive lower premiums on their health insurance.

Willingness to Use a Free Fitness Tracker Provided by a Physician

This exact strategy is being tested by Humana, an insurance company that recently announced a data-sharing partnership with Apple through their HealthKit app. Humana’s Vitality program ranks users based on their fitness data, and reports the information back to employers who can then offer the employees discounts on their monthly healthcare costs.

Given the clear interest among even non-tracking adults, and the success of similar self-monitoring programs for car insurance, it seems likely that additional carriers will begin to implement such initiatives. Based on the above responses, the impact on the health and fitness tracking market will be significant.

For maximum impact, healthcare providers and health insurance companies should partner together to promote self-tracking both in physician’s offices and during insurance enrollment. A combined effort could successfully convince over half of currently non-tracking adults to monitor such information. The resulting data would be a treasure trove for patient outcome research and preventative best practices.

Author Bio:
Cameron Graham is the Managing Editor at TechnologyAdvice, where he oversees original research and content strategy. He writes about healthcare IT, and emerging tech trends. Connect with him on LinkedIn.

Save the date! ePharma will take place February 24-26 in New York, NY.

Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  

Friday, October 3, 2014

ePharma Buzz- 10/3

Pin It Now!
Walter Cronkite once said, “You take a little pill of news every day - 23 minutes - and that's supposed to be enough.”  We’re not saying this is enough, but it’s a “little pill” of pharma news from the last seven days to get you started. 

FDA Reopening Comment Period on Social Media Draft Guidances, FDA.gov- If you were anxiously awaiting the next development from the FDA on their social guidances, you may be waiting even a little longer.  Effective September 29, The FDA extended the comment period 30 days for the set of guidances released June 17.  The organization has bought themselves some additional time but at the rate with which social media and digital is evolving, this could turn out to be somewhat of a moving target. 


Sales Rep Restrictions Point to Need for a Pharma Rethink, MM&M- You want to reach doctors directly with your products?  Get in line.  As we all know, this is becoming increasingly more difficult to do.  Research from Quantia shows that 32% are now unable to talk to reps—up from 27% last year.  In addition, 44% of doctors say they’re working in an organization now moving towards an Accountable Care Organization model, restricting rep contact even further. 


How Genentech Taps into Online Patient Communities to Improve Clinical Trials, mobihealthnews- “When it comes to designing a clinical trial, how do you actually put the patient first?” asks Joling Mew, Genentech product development leader.  For her company, part of that answer has consisted of working with online patient communities.  Mew cites some of these communities as being contributing factors to solving some difficult clinical trials cases and leading to greater enrollment and retention.  Genentech has had some breakthrough insights in leveraging these groups. Check out the article if you don’t believe us.  


HealthKit is Finally Live: Here’s How it (Really) Works, VentureBeat- Speculation about HealthKit has dominated blogs and news outlets since Apple first laid out their plans this spring. With the release of iOS 8, we now have more clarity on how the platform actually operates.  Here’s what we know (in short):  The iPhone owner is responsible for recording the metrics they wish to measure (i.e. weight, sleep, blood pressure) through selected health apps or hardware.  They then grant permission at the app level for HealthKit to use this data.  HealthKit aggregates that data and can provide it to third parties (upon the users permission).  

The Secret Recipe for Content Marketing Success, Healthline Blog- We’re admittedly a little bias here, this information was first presented at ePharma West last week.  David Kopp (@Kopportunity) reveled some of his secrets for content marketing that’ve lead to over 25 million monthly visitors for Healthline.  His “recipe for success”: 



Save the date! ePharma will take place February 24-26 in New York, NY.

This piece was contributed by @MikeMadarasz

Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  



Thursday, October 2, 2014

Session Spotlight: Moderated Discussion with Patient Opinion Leaders

Pin It Now!
We closed out ePharma West with a lively discussion on some of the biggest takeaways from the previous two and a half days. Brian Shields provides some of those key points for us below:  

Market Research from Patient Opinion Leaders

Moderator: Russ Fetteroff, (@digitalbulldog), Senior Vice President of Innovation, WEGO Health

Panelists: Mike Lawson, (@mrmikelawson), Type I Diabetes Health Activist and Britt Johnson (@HurtBlogger), Rheumatoid Arthritis and Migraine Health Activist

This was an exit panel led by Russ Fetteroff with some very straight shooting feedback for pharma from Mike Lawson and Britt Johnson.

Russ outlined the pharma translation of CRM:
     •   Ensure patients get off to a successful start with their medication
     •   Help patients understand how their medication works
     •   Support patients in taking their medication as prescribed
     •   Create and ongoing personal relationship with patients

Russ also highlighted Allergan’s My Tears, My Rewards program as a great example of a patient CRM program.

Britt and Mike provided excellent feedback based on focus group questions that Russ asked throughout the panel discussion, some of which is listed below:

•   Copay assistance cards are the number one patient need in the online community
•   Doctor’s recommendations are key to patients trusting pharma resources
•   Online patient advocates paid by pharma may lose the trust of their followers
•   Programs that inundate patients with glossy mailers, text messages, email and phone calls may be overwhelming.  Pharma CRM programs should allow patients to decide how they want to receive communications
•   A call to Britt from an Abbott nurse was an excellent example of patient focus by a company
•   Companies should include patients early in app development
•   Mike Lawson also discussed how videos can be very helpful, noting that he learned to test his blood glucose on YouTube

ePharma West Britt Johnson Mike Lawson Patient Opinion Leader
Britt Johnson and Mike Lawson tell all from the patient perspective


Save the date! ePharma will take place February 24-26 in New York, NY.

Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  


Tuesday, September 30, 2014

ePharma West Summary: Day Two

Pin It Now!
ePharma West is in the books. If you were following the action on Twitter, you may have gotten a look at some of the modern marketing techniques discussed.  If not, here are some of the highlights from Day two provided by Brian Shields.  


Shifting from ROI to REO, Return on Engagement
Mike Oberg, Senior Director, Marketing Apollo Endosurgery

Mike reviewed the learnings and success of Apollo Endosurgery as they focused the marketing for their Lap-Band product on online engagement with patients.

Overall, Mike explained that brands should be overwhelmingly positive to patients on social media.

The key takeaways for a return on engagement focus:
  •         Build an infrastructure that can help you scale social policies and governance
  •         Understand your audience
  •         Identify influencers, engage with them often
  •         Tell a story that adds value to the people you are trying to reach
  •         Support your social media efforts with paid media

Some other tips from Mike Oberg regarding their social media efforts:
  •          They have an agile social media policy, that allows them to use pre-approved                                    phrases in response to certain comments in real time
  •          The company has a full time community manager
  •          They have a list of 100 patient advocates that they share breaking news and                                      information with proactively, without any suggested messaging
  •          A monthly Twitter calendar is submitted for review each month
  •          Social Media allows them to create expanded reach with TV events and                                              happenings
o   Dr. Oz Segment
o   Corey from Pawn Stars on the Today Show


Walking Through the FDA’s Social Media Guidance, What does it Mean?
Mark S. Roh, Regional Food and Drug Director, Pacific Region, FDA

Mark Roh reviewed the FDA’s Social Media guidance with the group and provided some very clear slides for companies to use when evaluating their online efforts.

A helpful algorithm which outlines the responsibility of a firm and social media:
  •         Promotion by the Firm – The Firm is responsible
  •         Promotion by 3rd party on behalf of the firm – The Firm is responsible
  •         Promotion by 3rd party not associated with the firm

o   Is there any influence exerted by the Firm?
-  Yes- The Firm is responsible
-  No- Firm not responsible

He also provided guidance for marketing management on how to maintain control of social media. 

Responsible officials – ask yourself:
  •         What is the purpose of the labeling or promotional material?
  •         Who has control over the content or the placement of the material?
  •         How am I participating in this discussion?
  •         What information am I providing?

Monetizing Digital Opportunities in Medium-Sized Specialty Pharma
Brian Johnson, Principal, Two Hearts Group, @brianmjohnson4

Brian provided a helpful overview of the need for a Chief Digital Officer as well as their responsibilities.

Why do organizations need a Chief Digital Officer?

1. Brands are doing digital
2. Commercial Operations are doing digital
3. IT is doing digital
4. Sales is doing digital
5. But who owns it?

At Galderma, with the leadership of Brian, Chief Digital Officer, they focused on three key strategies to be successful:

1. Bring e-commerce to Cetaphil.com
2. Partner with Amazon to improve presence as largest online retailer
3. Expand digital communications to non-called on health care providers across brands and business units.

Brian also presented the case for digital communications to non-called on health care providers:

They want to communicate at their convenience
  •         When the want
  •         Where they want
  •         How they want
  •         About what they want
Brian also had this piece of advice for pharma companies: “Are you going to do the responsible thing and respond to your patients on social media, or hide behind regulatory and turn a blind eye?”

Finally, Brian shared that big pharma should consider more SAAS platforms vs creating digital platforms from scratch.  With Galderma, they used an SAAS ecommerce platform and were able to develop and launch the program in 90 days.

Follow us on Twitter
Join us on LinkedIn
Check us out Facebook  


Tuesday, September 23, 2014

ePharma West Summary: Pre-Conference Day

Pin It Now!
ePharma West got kicked off yesterday with our pre-conference day focused on content marketing.  If you couldn’t make it to San Francisco but are still wondering how to strategically generate quality content, you’re in luck.  Brian Shields summarized some of yesterday’s key sessions for us below.

Build trust by providing relevant content to your customers
Kevin Popovic, Communications Director Ideahaus LLC

Kevin presented to us an exciting case study on the brand development of his client.
Case Study:  Dr. Scott Andersen walked away from medicine to make a difference.  The result was Dr. A’s Habits of Health.

Kevin’s Team prioritized the following:
   - Create a communications platform
   - Develop national brand for Dr. A
   - Generate new opportunities

The team developed a presence across the most important channels:
   - Website
   - Mobile
   - iPad
   - Facebook
   - Instagram
   - Google

Images and video were the most effective sources of content and were utilized across platforms.  Specifically, images with daily motivational quotes were exceptional at generating engagement on Facebook.  Google+ generated great traffic while Facebook had the best engagement. Additionally, Instagram didn't seem to work for their older customer base.



They also created hats, t-shirts, etc to make their items on CafePress, a great source of brand development.

Summary of Successes
   + Presented a comprehensive brand
   + Packaged Dr. Wayne Andersen
   + Positioned as national personality
   + 4X increase in Web visits
   + More Media inquiries

Lessons learned
   + Start with good content
   + Packaging is imperative
   + Consistency is key
   + Amortize your investment
   + Have a plan
   + Measure your success

Tips for Success
   + Right down your goals and measurements of success up front
   + Create engagement
   + Capture moments and conversations

Communications Planning
   + Content development is an investment
   + Identify ROI in advance
   + Think about qualitative and quantitative metrics
   + Know where your audience is
   + Engagement means there is a conversation
   + Engage your audience
   + Make it easy for them the participate

Final Advice from Kevin, “Become the subject matter expert on your brand!”


Making the Most of Specific Channels: Connecting With HCPs On Their Channels
Jack Bilson III, @jackbilson3, VP, Product Innovation M3 USA

Jack provided a great overview of the online world and the specific differences between specialties and their preferences.

One key point on specialty brands: 50-70% of the active universe is ignored by pharma due to target lists.  This group of doctors that are ignored are five times more likely to be involved in a digital pharma sponsored program.

What are HCPs doing on social media?
 •  Doctors are using LinkedIn to find jobs
 •  They're using Facebook for “personal stuff”
 •  2/3 Primary care physicians are using HCP social media sites

Jack provided incredible insights on the digital preferences across specialties:

 •  Physicians value the face-to-face sales rep the most
 •  PCPs are the biggest fans of sales reps
 •  Oncologists are seeing fewer reps due to institutional practices
 •  Cardiologists like live programs more so than others
 •  Oncologists are the most difficult to focus on via digital promotion
 •  Dermatology specialists are three times more likely than PCPs to do an eDetail
 •  Oncologists have a high diversity of program preferences and they’re most satisfied with programs including a KOL
 •  Oncologists are all about the data and very topical in preference
 •  Urologists are five times more likely than a PCP to do a self-directed eDetail
 •  Self-directed eDetails and recorded KOL presentations score highly with urologists



Winning the Moment: Using Twitter to Engage in Real-Time
Jeremy Anderson, @jeremyanderson, Head of Healthcare, Twitter

Jeremy Anderson provided the group with a great summary of Twitter’s characteristics in the health care space:

Some basic facts about Twitter:
   + Twitter is live, public and conversational
   + 36 million patients and caregivers are on Twitter
   + Snickers and Listerine were among those able to capitalize on marketing during the #WorldCup
   + Ellen DeGeneres brought real time marketing with Twitter front and center with her famous Oscars Tweet

Twitter for Healthcare
   Branded profiles
   + Unbranded profiles
   + Clinical trial recruitment
   + Listening tools as a predictor or seasonal diseases –  i.e. allergy season

Healthcare conversations on Twitter:
   + Cancer 30M
   + Heart Disease 9M
   + Diabetes 8M
   + Back Pain 6M
   + Asthma 4.5M
   + Arthritis 1.5M

Twitter’s ad platforms are particularly successful when linked with live TV events. In the U.S., programs have seen an ROI increase between 8-16% when the Ad program is linked to a Twitter campaign.

Jeremy’s team is responsible for working with Pharma and the FDA to develop programs that add value to patients and meet the regulatory guidelines.


You can follow the rest of the conference by keeping tabs on #ePharma or following us at @ePharma over the next two days.